Search News + Media

In 2014, John White was diagnosed with prostate cancer and given a couple of years to live. Now, he’s a committed advocate for those living with cancer.

Tufts Medicine delivers precision medicine theranostic radiation treatment to patients with advanced prostate cancer.

MelroseWakefield Hospital's Dr. Tony Luongo shares what you should know about the risks and treatment options for prostate cancer.

Half of all men ages 51 to 60 have benign prostatic hyperplasia (BPH) and the incidence increases every decade of life.

MelroseWakefield Hospital is the first in New England to offer Aquablation therapy for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH).

Prostate cancer is the most common cancer in American men and also the most common non-skin cancer among all Americans.